|
|
Constructing Mouse pET3C-Myc Vector and Its Expression in Rosetta(DE3) and Its Purification |
XIANG Li1, WANG Shen2, TIAN Hai-shan2, ZHONG Mei-juan1, ZHOU Ru-bin1, CAO Ding-guo1, LIANG Peng1, ZHANG Guo-ping1, HE Tao1, PANG Shi-feng1 |
1. Department of Biology, Guangdong Medical University, Dongguang 523808, China;
2. School of Pharmaceutical Science, Wenzhou Medical University, Wenzhou 325035, China |
|
|
Abstract Objective: The object is to construct prokaryotic expression vector which carried mouse cloned c-Myc gene, and achieve its expression and then purify the product.Methods: TetO-FUW-OSKM plasmid was used as a templet to amplify c-Myc gene fragment by polymerase chain polymerization reaction (PCR). After inserting into pET3C vector, the c-Myc gene was transformed into E.coli DH5α. The eligible recombinant plasmid pET3C-Myc was screened out after resistance selection, restrictive identification by PCR, and sequencing and then transformed into E.coli Rosetta (DE3).Result: The result of DNA agarose gel electrophoresis show the amplified gene met the size of destination gene. The sequencing of the reconstructed gene was the same as that of in GenBank. Reaching the destination, the purified product proved to have about 64kDa by SDS-PAGE test. Conclusion: It is successful to construct the recombinant plasmid pET3C-Myc, and achieve its expression in the Rosetta (DE3) and purify the product. The above success paves the path for next study.
|
Received: 04 November 2016
Published: 25 February 2017
|
|
|
Cite this article:
XIANG Li, WANG Shen, TIAN Hai-shan, ZHONG Mei-juan, ZHOU Ru-bin, CAO Ding-guo, LIANG Peng, ZHANG Guo-ping, HE Tao, PANG Shi-feng. Constructing Mouse pET3C-Myc Vector and Its Expression in Rosetta(DE3) and Its Purification. China Biotechnology, 2017, 37(2): 20-25.
URL:
https://manu60.magtech.com.cn/biotech/10.13523/j.cb.20170204 OR https://manu60.magtech.com.cn/biotech/Y2017/V37/I2/20
|
|
|
[1] Neel B G, Suresh C, Jhanwar R S, et al. Two human C-onc genes are located on the long arm of chromosome8. Proceedings of the National Academy of Science,1982,79:7842-7846.
[2] Jim B, Christopher M, Rebecca T, et al. The human c-Myc oncogene:Structural consequence of translocation into the igh locus in Byrkitt lymphoma. Cell, 1983,34(3):779-787.
[3] 石晶,石爱海.端粒、端粒酶、c-myc与肿瘤.临床口腔医学杂志,2004,20(1):61-62. Shi J,Shi A H. Telomere,telomerase,c-Myc and tumor. Jounal of Clinical Stomatology,2004,20(1):61-62.
[4] Cartwright P, McLean C, Sheppard A, et al. LIF/STAT3 controls ES cell self-renewal and pluripotency by a Myc-dependent mechanism. Development, 2005,132(5):885-896.
[5] De Sauvage F J, Carver-Moore K, Luoh S M, et al. Physiological regulation of early and late stages of megakaryocytopoiesis by thrombopoietin. J Exp Med, 1996,183(2):651-656.
[6] Kaushansky K, Drachman J G. The molecular and cellular biology of thrombopoietin:the primary regulator of platelet production. Oncogene, 2002,21:3359-3367.
[7] Davis A C, Wires M, Spotts G D, et al. A null c-Myc mutation causes lethality before 10.5 days of gestation in homozygotes and reduced fertility in heterozygous female mice. Genes & Development,1993, 7(4):671-682.
[8] 孙慧慧,朴敬爱,李文哲,等.原核表达c-Myc蛋白的多克隆抗体制备.安微农学报,2011,17(1):56-58. Sun H H, Pu J A, Li W Z, et al.prokaryotic expression of C-Myc protein and preparation for polyclonal antibody. Anhui Agricultural Science Bulletin,2011,17(1):56-58.
[9] Fernandez P C, Frank S R, Wang L, et al. Genomic targets of the human c-Myc protein. Genes Dev, 2003, 17(9):1115-1129.
[10] Pera M F, Hasegawa K. Simpler and safer cell reprogramming. Nat Biotechnol, 2008,26(1):59-60.
[11] 杨阳, 刘斌, 庞卯,等. 蛋白诱导诱导多能干细胞技术的研究进展. 中华生物医学工程杂志, 2013, 19(3):249-252. Yang Y, Liu B, Pang M, et al.The research progress of protein induced pluripotent stem cells.Chin J Biomed Eng, 2013,19(3):249-252.
[12] Liao J,Cui C,Chen S,et al.Generation of induced pluripotent stemcelllines from adult rat cells.Cell Stem Cell, 2009,4:11-15.
[13] Yung S K,Tilgner K,Ledran M H,et al.Brief report:human pluripotent stem cell models of fanconi anemia deficiency revealan important role for fanconi anemia proteins in cellular reprogramming and survival of hematopoietic progenitors.Stem Cells,2013,31:1022-1029.
[14] 马海滨,侯玲玲,王晓宇,等.诱导性多潜能干细胞(IPS细胞)的研究进展.中国生物工程杂志,2011,31(8):124-132. Ma H B, Hou L L, Wang X Y,et al. The progress of induced pluripotent stem cell(ips cells). China Biotechnology,2011,31(8):124-132.
[15] Evan G I, Hancock D C. Studies on the interaction of the human c-myc protein with cell nuclei:p62c-myc as a member of a discrete subset of nuclear proteins. Cell, 1985, 43(1):253-261.
[16] 王伟,孟超,朱平,等. 绿色荧光蛋白标记的表达载体p-His EGFP 的构建.中国生物工程杂志,2005,25(9):35-39. Wang W,Meng C, Zhu P, et al. Construction of an expression vector pHis-EGFP with the enhanced green fluorescent protein(EGFP) gene. China Biotechnology, 2005, 25(9):35-39. |
|
Viewed |
|
|
|
Full text
|
|
|
|
|
Abstract
|
|
|
|
|
Cited |
|
|
|
|
|
Shared |
|
|
|
|
|
Discussed |
|
|
|
|